Increased JNK activation with the progression of hepatic steatosis reduces peroxisome β-oxidation by suppressing peroxisome proliferator-activated receptor α (PPARα) activity, in part through the upregulation of nuclear receptor corepressor 1 (NCoR1) [79]. This evidence concerns the gene MAPK8 and fatty liver disease.